Study of KarXT plus KarX-EC for irritability in children with autism
Part of Mental health clinical trials.
This trial tests a combination of two drugs, KarXT and KarX-EC, to see if they can reduce irritability in children and teens with autism spectrum disorder. If your child has significant irritability linked to their autism, this study may offer a new treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a confirmed diagnosis of autism spectrum disorder.
- Your child must be experiencing significant irritability, such as outbursts or aggression.
- Your child must not have certain other diagnoses like bipolar disorder, schizophrenia, or major depression.
- It's okay if your child has ADHD as long as it is not the main problem and is well-controlled.
- Your child must not have serious medical issues or be at risk for suicidal behavior.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of two medications (KarXT and KarX-EC) can help reduce irritability in children and teens with autism. It's for those who have significant irritability symptoms that affect daily life.
This study tests an investigational medication called lumateperone to see if it can reduce irritability in children and teens with autism. It is for teenagers aged 13–17 whose irritability is causing significant problems.
This study tests a new medication called Lumateperone to see if it can reduce irritability in children and teens with autism. It's a 3-month trial that compares the study drug to a placebo (a pill with no active medicine) to find out if it helps with mood and behavior.
This trial tests if KarXT, taken with KarX-EC, is safe and effective for long-term treatment of agitation in Alzheimer's disease. It is for people who already completed a previous KarXT study.
This study tests a new drug combination (KarXT + KarX-EC) to see if it can safely reduce agitation in people with Alzheimer's disease. It may help if you or your loved one has bothersome agitation that affects daily life.
This study tests the long-term safety of KarXT for people with bipolar I disorder who are having a manic or mixed episode. It is for people who either completed a previous KarXT study or are new to the study and have moderate to severe mania symptoms.
Hear when a new Irritability Associated With Autism Spectrum Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.